Regeneron Pharma Q2 Results Top Estimates - Update

Regeneron Pharma Expects Q4 Results To Include $24 Mln In Acquired In-process R&D Charge

Regeneron Pharmaceuticals, Inc. (REGN) said Monday it currently expects that its financial results for the second quarter 2024 will include an acquired in-process research and development charge of approximately $24 million on a pre-tax basis.

RTTNews | 182 days ago

Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorization of odronextamab to treat adults with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.

RTTNews | 192 days ago

Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharmaceuticals, Inc. (REGN) reported on Friday that net income for the fourth quarter declined 3 percent to $1.16 billion or $10.19 per share from $1.20 billion or $10.50 per share in the prior-year quarter.

RTTNews | 339 days ago

Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.

RTTNews | 920 days ago

Eurozone Economy On The Verge Of Deeper Crisis, Sentix Says

The euro area economy is in the danger of plunging even deeper into crisis and the room for the European Central Bank for maneuver is diminishing rapidly, the behavioral research institute Sentix said Monday. Eurozone investor confidence sunk to the lowest level since November 2023 with the corresponding index falling to -17.7 in January from -17.5 in December, results of the monthly survey by S

RTTNews | 5h 29min ago

Euro Rises Against Majors

The euro strengthened against other major currencies in the European session on Monday. The euro rose to a 6-day high of 0.9391 against the Swiss franc and a 4-day high of 0.8315 against the pound, from early lows of 0.9369 and 0.8286, respectively.

RTTNews | 6h 13min ago

Eurozone Private Sector Shrinks Marginally

The euro area private sector contracted only fractionally in December as services activity bounced back, final results of the purchasing managers' survey by S&P Global showed on Monday. The composite output index rose to 49.6 in December from 48.3 in the previous month. The score was slightly above the flash estimate of 49.5.

RTTNews | 6h 47min ago

FTSE 100 Down Marginally In Cautious Trade

U.K. stocks are down in negative territory Monday morning, weighed down by rating downgrades of a few big name stocks.

RTTNews | 7h 31min ago

EURUSD	1.04197	GBPUSD	1.25421	AUDUSD	0.62921
USDJPY	156.668	USDCAD	1.4313	USDCHF	0.90126